Valued at $154.6M at its early-stage round, Oct 2025. Nothing has traded since.
- ·Watch Pheast Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Pheast Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC | $24.6M | ▮ | ▮ |
| Jan 2022 | Later Stage VC | $75.3M | ▮ | ▮ |
Membership and data by Private Market View
Pheast Therapeutics valuation
Pheast Therapeutics was valued at $155 million at its early-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Pheast Therapeutics raised?
Pheast Therapeutics has raised $101 million across 2 recorded rounds since 2022. The largest was a $75.3 million later-stage round in Jan 2022; the most recent was a $24.6 million early-stage round in Oct 2025.
Pheast Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Apr 2025 ($75.3 million sold to 7 investors).
How Pheast Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Pheast Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Pheast Therapeutics
- What is Pheast Therapeutics worth?
- Pheast Therapeutics is valued at $154.6M as of Oct 2026. Valued at $154.6M at its early-stage round, Oct 2025. Nothing has traded since.
- How much has Pheast Therapeutics raised?
- Pheast Therapeutics has raised $100.6M in total funding across 2 recorded rounds.
- When did Pheast Therapeutics last raise?
- Pheast Therapeutics last raised in Oct 2025 (Early Stage VC), raising $24.6M.